메뉴 건너뛰기




Volumn 104, Issue 1, 2002, Pages 54-56

Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin

Author keywords

Dalfopristin; Enterococcus; Intraventricular; Linezolid; Meningitis; Quinupristin; Shunt; Vancomycin

Indexed keywords

CEFTRIAXONE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; PENICILLIN G; QUINUPRISTIN; VANCOMYCIN;

EID: 0036137347     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(01)00180-9     Document Type: Article
Times cited : (32)

References (10)
  • 2
    • 2042546477 scopus 로고    scopus 로고
    • Rhone-Poulenc Rorer Pharmaceuticals, Inc. Synercid® prescribing information. Collegeville, PA: Rhone-Poulenc Rorer Pharmaceuticals, Inc., 1999.
  • 3
    • 2042514058 scopus 로고    scopus 로고
    • Nachman SA, Phillips A, Gray SL, Talbot GH. Treatment of vancomycin-resistant Enterococcus faecium central nervous system infection with intrathecal administration of quinupristin-dalfopristin [Abstract]. Programs and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24-27, 1998. Washington, DC: American Society for Microbiology; 1998. p. 217.
  • 10
    • 2042545843 scopus 로고    scopus 로고
    • Vouillamoz J, Entenza JM, Giddey M, Glauser MP, Moreillon P. In vitro activity of synercid (quinupristin/dalfopristin) (SYN) combined with other classes of antibiotics against vancomycin-susceptible (VS) E. faecalis and vancomycin-susceptible or -resistant (VR) E. faecium (VSEF and VREF) [Abstract]. Programs and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 15-18, 1996. Washington, DC: American Society for Microbiology; 1996. p. 82.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.